Research Store

Research Store

Research Store
add to cart Register yourself and then log-in with your user ID and password, before clicking on 'Add to Cart'
Issue Date:29 May 2017     Price in Rs. R 6500    Price in USD. $ 100

Hetero is one of the leading Indian generic pharmaceutical companies. It is among the top 50 pharma companies in the domestic formulation business. It is also one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS, and is actively working on building a global franchise of oncology products both in API’s and finished dosages.

In terms of focus, Hetero business is structured around four verticals, and it serves the global biopharmaceutical industry with the global standrard products and services

  1. API
  2. Generic Formulations
  3. CPS - Customised Production Services
  4. Biologics

R&D is a significant focus area for the company, with more than 500 strong team of scientists,with comptencies in the area of developing generics, complex APIs (Active Pharmaceutical Ingredients), formulations, Novel Drug Delivery Systems (NDDS), New Chemical Entities (NCEs) and Biosimilar products. Thus having a healthy pipeline of  new products.

Manufacturing is the area in which Hetero has made substantial investments. It has over 25 state-of-the-art manufacturing facilities across the world - located in India, China, Russia, Egypt and Mexico. These plants are approved by various global regulatory bodies like USFDA, EUGMP,TGA-Australia, PMDA-Japan, MHRA-UK and others

Financially, in the FY 16, company clocked Rs. 6900 crore revenue and Rs. 1916 crore operating profit (excluding 'other income' of Rs. 180 crore). With interest and depreciation being at Rs. 168 crore and Rs. 126 crore respectively, company PBT was at Rs. 1802 crore. PAT was Rs. 1389 crore. Total debt for the company stood at over Rs. 2200 crore. Of its total revenue, nearly Rs. 442 crore was contributed by the domestic formulation business

  1. Company Background
  2. Business Highlights
  3. Financial Performance
  4. Financial Details


  1. Board of Directors
  2. Financial Summary
  3. Profit & Loss Account
  4. Balance Sheet
  5. Ratios


Hetero Drugs